Case report: Alpelisib-induced Stevens–Johnson syndrome

BACKGROUND: Alpelisib is a recently approved treatment for hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer. It has been associated with alopecia and rash, but there are no documented cases of Stevens–Johnson Syndrome (SJS) associated with this drug. Here, we detail th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurian, Christine Jane, Desai, Akshay, Rafferty, William, Abou Hussein, Ahmed Kamel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554210/
https://www.ncbi.nlm.nih.gov/pubmed/36249040
http://dx.doi.org/10.3389/fonc.2022.954027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554210/
https://www.ncbi.nlm.nih.gov/pubmed/36249040
http://dx.doi.org/10.3389/fonc.2022.954027

Ejemplares similares